Literature DB >> 25602597

Coronary artery disease and transcatheter aortic valve replacement: current treatment paradigms.

Jean-Michel Paradis1, Benoit Labbé, Josep Rodés-Cabau.   

Abstract

Aortic stenosis is the most common form of valvular heart disease in the elderly population and is often diagnosed in individuals who also have coronary artery disease. Surgical aortic valve replacement has been the standard of care for the treatment of aortic stenosis during the past decades, but the availability of transcatheter aortic valve replacement has now allowed different options for high or extreme surgical risk patients. The management of coronary artery disease in patients undergoing transcatheter aortic valve replacement remains a controversial issue, as available studies in the literature have generated conflicting results. This review offers a comprehensive portrait of coronary artery disease management in the presence of concomitant aortic stenosis and proposes treatment approaches for patients presenting both diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25602597     DOI: 10.1097/MCA.0000000000000210

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

1.  Does the presence of coronary artery disease affect the outcome of aortic valve replacement?

Authors:  Kaoru Matsuura; Hideki Ueda; Hiroki Kohno; Yusaku Tamura; Michiko Watanabe; Tomohiko Inui; Yuichi Inage; Yasunori Yakita; Goro Matsumiya
Journal:  Heart Vessels       Date:  2017-07-25       Impact factor: 2.037

2.  Routine CT angiography to detect severe coronary artery disease prior to transcatheter aortic valve replacement.

Authors:  S Chava; G Gentchos; A Abernethy; B Leavitt; E Terrien; H L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

Review 3.  Challenges in Diagnosis and Functional Assessment of Coronary Artery Disease in Patients With Severe Aortic Stenosis.

Authors:  Srdjan Aleksandric; Marko Banovic; Branko Beleslin
Journal:  Front Cardiovasc Med       Date:  2022-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.